Safeguarding Advanced Therapies—The Dangers of Therapeutic Neuroabandonment: How Should We Ensure Patient Safety and Scientific Integrity When a Commercial Clinical Trial Sponsor Becomes Insolvent?

Authors

Institutions

Publication Details

Journal
Movement Disorders
Published
2026-05-29
DOI
https://doi.org/10.1002/mds.70379
Primary Topic
Biomedical Ethics and Regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safeguarding Advanced Therapies—The Dangers of Therapeutic Neuroabandonment: How Should We Ensure Patient Safety and Scientific Integrity When a Commercial Clinical Trial Sponsor Becomes Insolvent?

Saeed Kayhanian, Roger A. Barker, Simon Rowe
Movement Disorders
Biomedical Ethics and Regulation
article

Safeguarding Advanced Therapies—The Dangers of Therapeutic Neuroabandonment: How Should We Ensure Patient Safety and Scientific Integrity When a Commercial Clinical Trial Sponsor Becomes Insolvent?

Saeed Kayhanian, Roger A. Barker, Simon Rowe
article en

Abstract

No abstract available for this paper.
Movement Disorders
Wellcome/MRC Cambridge Stem Cell Institute (GB), Cambridge University Hospitals NHS Foundation Trust (GB), UNSW Sydney (AU), Bridge University (SS)
Openalex Percentile: Top 6%
Biomedical Ethics and Regulation
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.